Cargando…
Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study
INTRODUCTION: Approximately 15 to 33% of all dialysis treatments are complicated by intradialytic hypotension (IDH). In this study, we tested the hypothesis that the intravenous administration of hydrocortisone prior to HD treatment could prevent IDH or at least decrease the drop in the blood pressu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654564/ https://www.ncbi.nlm.nih.gov/pubmed/34901264 http://dx.doi.org/10.1155/2020/4987547 |
_version_ | 1784611888567418880 |
---|---|
author | Alhawari, Hussein H. Alshelleh, Sameeha Alhawari, Hussam H. Alawwa, Izzat Ahmad AlRyalat, Saif Aldeen Mesmar, Ahmad Ojjoh, Khaled Alzoubi, Karem H. |
author_facet | Alhawari, Hussein H. Alshelleh, Sameeha Alhawari, Hussam H. Alawwa, Izzat Ahmad AlRyalat, Saif Aldeen Mesmar, Ahmad Ojjoh, Khaled Alzoubi, Karem H. |
author_sort | Alhawari, Hussein H. |
collection | PubMed |
description | INTRODUCTION: Approximately 15 to 33% of all dialysis treatments are complicated by intradialytic hypotension (IDH). In this study, we tested the hypothesis that the intravenous administration of hydrocortisone prior to HD treatment could prevent IDH or at least decrease the drop in the blood pressure resulting from IDH. METHODS: This study was approved by our local ethics committee/IRB (2017/87) and by the Jordan Food and Drug Administration (7/clinical/18). Additionally, it is registered on ClinicalTrials.gov (NCT03465007). In this preliminary investigational study, we screened all chronic hemodialysis patients at our clinic who were 18 years of age or older (n = 82) for IDH. There were 14 patients included in the interventional part of this study; patients were given IV hydrocortisone for 3 consecutive HD sessions, followed or preceded by 3 intervention-free sessions where they were given 5 ml of saline as a placebo. RESULTS: The initial total sample size was 82 patients. The frequency of IDH at our clinic was 24.4%. Fourteen out of the 20 patients who were diagnosed with IDH agreed to enroll in the interventional part of our study. The mean age of the patients in the interventional part of our study was 53.5 years (±10.3). These patients included 5 (35.7%) men and 9 (64.3%) women. Upon comparing the number of hypotensive attacks with and without the hydrocortisone administration, we found a significant difference (p = 0.003) between the hydrocortisone and placebo treatments in which 12 (85.7%) patients had fewer IDH episodes with the hydrocortisone treatment than with placebo. CONCLUSION: This preliminary investigational study found that the administration of a stress dose of hydrocortisone prior to hemodialysis could be an effective measure for preventing or minimizing the risk of IDH episodes. Additional prospective studies on this subject are needed. Ruling out adrenal insufficiency in patients diagnosed with IDH is also crucial. |
format | Online Article Text |
id | pubmed-8654564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-86545642021-12-09 Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study Alhawari, Hussein H. Alshelleh, Sameeha Alhawari, Hussam H. Alawwa, Izzat Ahmad AlRyalat, Saif Aldeen Mesmar, Ahmad Ojjoh, Khaled Alzoubi, Karem H. Biomed Res Int Clinical Study INTRODUCTION: Approximately 15 to 33% of all dialysis treatments are complicated by intradialytic hypotension (IDH). In this study, we tested the hypothesis that the intravenous administration of hydrocortisone prior to HD treatment could prevent IDH or at least decrease the drop in the blood pressure resulting from IDH. METHODS: This study was approved by our local ethics committee/IRB (2017/87) and by the Jordan Food and Drug Administration (7/clinical/18). Additionally, it is registered on ClinicalTrials.gov (NCT03465007). In this preliminary investigational study, we screened all chronic hemodialysis patients at our clinic who were 18 years of age or older (n = 82) for IDH. There were 14 patients included in the interventional part of this study; patients were given IV hydrocortisone for 3 consecutive HD sessions, followed or preceded by 3 intervention-free sessions where they were given 5 ml of saline as a placebo. RESULTS: The initial total sample size was 82 patients. The frequency of IDH at our clinic was 24.4%. Fourteen out of the 20 patients who were diagnosed with IDH agreed to enroll in the interventional part of our study. The mean age of the patients in the interventional part of our study was 53.5 years (±10.3). These patients included 5 (35.7%) men and 9 (64.3%) women. Upon comparing the number of hypotensive attacks with and without the hydrocortisone administration, we found a significant difference (p = 0.003) between the hydrocortisone and placebo treatments in which 12 (85.7%) patients had fewer IDH episodes with the hydrocortisone treatment than with placebo. CONCLUSION: This preliminary investigational study found that the administration of a stress dose of hydrocortisone prior to hemodialysis could be an effective measure for preventing or minimizing the risk of IDH episodes. Additional prospective studies on this subject are needed. Ruling out adrenal insufficiency in patients diagnosed with IDH is also crucial. Hindawi 2020-05-05 /pmc/articles/PMC8654564/ /pubmed/34901264 http://dx.doi.org/10.1155/2020/4987547 Text en Copyright © 2020 Hussein H. Alhawari et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Alhawari, Hussein H. Alshelleh, Sameeha Alhawari, Hussam H. Alawwa, Izzat Ahmad AlRyalat, Saif Aldeen Mesmar, Ahmad Ojjoh, Khaled Alzoubi, Karem H. Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study |
title | Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study |
title_full | Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study |
title_fullStr | Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study |
title_full_unstemmed | Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study |
title_short | Effect of Hydrocortisone on Intradialytic Hypotension: A Preliminary Investigational Study |
title_sort | effect of hydrocortisone on intradialytic hypotension: a preliminary investigational study |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654564/ https://www.ncbi.nlm.nih.gov/pubmed/34901264 http://dx.doi.org/10.1155/2020/4987547 |
work_keys_str_mv | AT alhawarihusseinh effectofhydrocortisoneonintradialytichypotensionapreliminaryinvestigationalstudy AT alshellehsameeha effectofhydrocortisoneonintradialytichypotensionapreliminaryinvestigationalstudy AT alhawarihussamh effectofhydrocortisoneonintradialytichypotensionapreliminaryinvestigationalstudy AT alawwaizzatahmad effectofhydrocortisoneonintradialytichypotensionapreliminaryinvestigationalstudy AT alryalatsaifaldeen effectofhydrocortisoneonintradialytichypotensionapreliminaryinvestigationalstudy AT mesmarahmad effectofhydrocortisoneonintradialytichypotensionapreliminaryinvestigationalstudy AT ojjohkhaled effectofhydrocortisoneonintradialytichypotensionapreliminaryinvestigationalstudy AT alzoubikaremh effectofhydrocortisoneonintradialytichypotensionapreliminaryinvestigationalstudy |